Manipulation of Medicinal Products for Oral Administration to Paediatric Patients at a German University Hospital: An Observational Study.

age-appropriate formulation drug manipulation hospital off-label use/manipulation oral drug administration paediatrics

Journal

Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003

Informations de publication

Date de publication:
23 Jun 2020
Historique:
received: 30 05 2020
revised: 17 06 2020
accepted: 20 06 2020
entrez: 27 6 2020
pubmed: 27 6 2020
medline: 27 6 2020
Statut: epublish

Résumé

Pharmacotherapy in children requires medicinal products in age-appropriate dosage forms and flexible dose strengths. Healthcare professionals often encounter a lack of licensed and commercially available formulations, which results in the need for manipulation. This study aimed to investigate the nature, frequency and preventability of the manipulation of medicinal products before oral drug administration to paediatric inpatients in Germany. A prospective, direct observational approach was used. Two thousand and three medication preparation processes (MPP) in 193 patients were included in the analysis. Medicines were manipulated in 37% of oral administrations, affecting 57% of the patients. The percentage of manipulations was highest in infants/toddlers (42%) and lowest in adolescents (31%). Antiepileptics were most frequently manipulated (27%), followed by vitamins (20%) and drugs for acid-related disorders (13%). Fifty-six per cent of all manipulations were off-label. In 71% of these, no alternative appropriate medicinal product was commercially available. These results demonstrate that the manipulation of medicinal products before oral administration is common in paediatric wards in Germany. About half of the manipulations were off-label, indicating that no suitable formulation was available. Evidence-based guidelines for manipulations are required, with the overall aim of improving the safety of paediatric drug therapy.

Identifiants

pubmed: 32586000
pii: pharmaceutics12060583
doi: 10.3390/pharmaceutics12060583
pmc: PMC7355957
pii:
doi:

Types de publication

Journal Article

Langues

eng

Commentaires et corrections

Type : ErratumIn

Références

Eur J Clin Pharmacol. 2014 May;70(5):565-73
pubmed: 24468805
Expert Opin Drug Metab Toxicol. 2020 Mar;16(3):227-238
pubmed: 32054370
CMAJ. 2005 Mar 29;172(7):871-2
pubmed: 15795404
J Acquir Immune Defic Syndr. 2011 Dec 1;58(4):385-91
pubmed: 21876444
Int J Mol Sci. 2019 May 31;20(11):
pubmed: 31159216
N Engl J Med. 2003 Sep 18;349(12):1157-67
pubmed: 13679531
J Emerg Nurs. 2010 Mar;36(2):156-8
pubmed: 20211410
Expert Opin Drug Deliv. 2007 Jan;4(1):37-45
pubmed: 17184161
Acta Paediatr. 2017 Mar;106(3):503-508
pubmed: 27935163
Acta Paediatr. 2020 Feb 7;:
pubmed: 32034802
Int J Pharm. 2013 Nov 30;457(1):339-41
pubmed: 24216239
Int J Pharm. 2017 Feb 25;518(1-2):155-166
pubmed: 28040560
Paediatr Drugs. 2014 Oct;16(5):397-406
pubmed: 25056717
Acta Paediatr. 2019 Aug;108(8):1475-1481
pubmed: 30632630
Dtsch Arztebl Int. 2015 Nov 13;112(46):781-7
pubmed: 26806565
Pharmaceutics. 2016 Jan 07;8(1):
pubmed: 26751472
Arch Dis Child. 2016 Jul;101(7):662-9
pubmed: 26979250
J Clin Nurs. 2015 Oct;24(19-20):3016-9
pubmed: 26215762
Arch Pediatr. 2004 Oct;11(10):1173-84
pubmed: 15475272
Int J Pharm. 2005 Aug 26;300(1-2):56-66
pubmed: 15979830
Epilepsy Behav. 2018 May;82:133-139
pubmed: 29625363
J Am Pharm Assoc (Wash). 2002 Mar-Apr;42(2):200-5
pubmed: 11926663
Br J Clin Pharmacol. 2011 Dec;72(6):990-6
pubmed: 21658093
BMC Pediatr. 2013 May 21;13:81
pubmed: 23688279

Auteurs

Julia Zahn (J)

Department of Paediatrics and Adolescent Medicine, Universitätsklinikum Erlangen, 91054 Erlangen, Germany.

André Hoerning (A)

Department of Paediatrics and Adolescent Medicine, Universitätsklinikum Erlangen, 91054 Erlangen, Germany.

Regina Trollmann (R)

Department of Paediatrics and Adolescent Medicine, Universitätsklinikum Erlangen, 91054 Erlangen, Germany.

Wolfgang Rascher (W)

Department of Paediatrics and Adolescent Medicine, Universitätsklinikum Erlangen, 91054 Erlangen, Germany.

Antje Neubert (A)

Department of Paediatrics and Adolescent Medicine, Universitätsklinikum Erlangen, 91054 Erlangen, Germany.

Classifications MeSH